AbbVie (NYSE:ABBV) reported its Q1 earnings results on Friday, April 29, 2022 at 07:44 AM.
Here's what investors need to know about the announcement.
Earnings
AbbVie beat estimated earnings by 0.64%, reporting an EPS of $3.16 versus an estimate of $3.14.
Revenue was up $528.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 1.52% increase in the share price the next day.
Here's a look at AbbVie's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.28 | 3.22 | 3.09 | 2.83 |
| EPS Actual | 3.31 | 3.33 | 3.11 | 2.95 |
| Revenue Estimate | 14.98B | 14.32B | 13.63B | 12.76B |
| Revenue Actual | 14.89B | 14.34B | 13.96B | 13.01B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
AbbVie management provided guidance for FY 2022, expecting earnings between $13.92 and $14.12 per share.
To track all earnings releases for AbbVie visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
